Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-4692

Zeilhofer, H U (2007). Prostanoids in nociception and pain. Biochemical Pharmacology, 73(2):165-174.

[img] PDF - Registered users only
392kB

Abstract

Prostaglandins are lipid mediators produced by cyclooxygenases from arachidonic acid, which serve pivotal functions in inflammation and pain. Inhibition of their production is the major analgesic mechanism of action of non-steroidal anti-inflammatory drugs (NSAIDs)-but also the source of most of their unwanted effects. While the development of selective inhibitors of inducible cyclooxygenase (COX)-2 (so called coxibs) has greatly reduced gastrointestinal side effects, the recent disappointment about a potential cardiovascular toxicity of COX-2-selective inhibitors has boosted interest in alternative targets. The discovery of several prostaglandin synthases and of distinct prostaglandin receptors has unraveled an unforeseen diversity within the prostanoid synthetic pathway. Behavioral and electrophysiological work in particular with genetically engineered mice meanwhile provides new clues to the role of different prostaglandins, prostaglandin synthases and prostaglandin receptors in pain pathways.

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Institute of Pharmacology and Toxicology
DDC:570 Life sciences; biology
610 Medicine & health
Language:English
Date:15 January 2007
Deposited On:20 Mar 2009 12:32
Last Modified:02 Dec 2013 16:18
Publisher:Elsevier
ISSN:0006-2952
Publisher DOI:10.1016/j.bcp.2006.07.037
PubMed ID:16959219
Citations:Web of Science®. Times Cited: 39
Google Scholar™
Scopus®. Citation Count: 47

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page